Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.
Publication
, Journal Article
Hurst, JH
Published in: J Clin Invest
October 1, 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
October 1, 2015
Volume
125
Issue
10
Start / End Page
3732 / 3736
Location
United States
Related Subject Headings
- Texas
- T-Lymphocyte Subsets
- Receptors, Antigen, T-Cell
- Randomized Controlled Trials as Topic
- New York
- Neoplasms
- Mice
- Melanoma
- Medical Oncology
- Lymphocyte Activation
Citation
APA
Chicago
ICMJE
MLA
NLM
Hurst, J. H. (2015). Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award. J Clin Invest, 125(10), 3732–3736. https://doi.org/10.1172/JCI84236
Hurst, Jillian H. “Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.” J Clin Invest 125, no. 10 (October 1, 2015): 3732–36. https://doi.org/10.1172/JCI84236.
Hurst JH. Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award. J Clin Invest. 2015 Oct 1;125(10):3732–6.
Hurst, Jillian H. “Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.” J Clin Invest, vol. 125, no. 10, Oct. 2015, pp. 3732–36. Pubmed, doi:10.1172/JCI84236.
Hurst JH. Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award. J Clin Invest. 2015 Oct 1;125(10):3732–3736.
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
October 1, 2015
Volume
125
Issue
10
Start / End Page
3732 / 3736
Location
United States
Related Subject Headings
- Texas
- T-Lymphocyte Subsets
- Receptors, Antigen, T-Cell
- Randomized Controlled Trials as Topic
- New York
- Neoplasms
- Mice
- Melanoma
- Medical Oncology
- Lymphocyte Activation